JP2012521404A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012521404A5 JP2012521404A5 JP2012501410A JP2012501410A JP2012521404A5 JP 2012521404 A5 JP2012521404 A5 JP 2012521404A5 JP 2012501410 A JP2012501410 A JP 2012501410A JP 2012501410 A JP2012501410 A JP 2012501410A JP 2012521404 A5 JP2012521404 A5 JP 2012521404A5
- Authority
- JP
- Japan
- Prior art keywords
- los
- composition
- composition according
- item
- motomeko
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000004044 tetrasaccharides Chemical class 0.000 claims description 10
- 150000001720 carbohydrates Chemical class 0.000 claims description 9
- 230000002163 immunogen Effects 0.000 claims description 8
- 108010078791 Carrier Proteins Proteins 0.000 claims description 6
- 102000014914 Carrier Proteins Human genes 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 6
- 108090000790 Enzymes Proteins 0.000 claims description 6
- 230000000694 effects Effects 0.000 claims description 6
- 241000588650 Neisseria meningitidis Species 0.000 claims description 5
- 241000124008 Mammalia Species 0.000 claims description 4
- 239000002671 adjuvant Substances 0.000 claims description 4
- 230000028993 immune response Effects 0.000 claims description 4
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims description 3
- 108010071134 CRM197 (non-toxic variant of diphtheria toxin) Proteins 0.000 claims description 2
- 102100037840 Dehydrogenase/reductase SDR family member 2, mitochondrial Human genes 0.000 claims description 2
- 101710188053 Protein D Proteins 0.000 claims description 2
- 101710132893 Resolvase Proteins 0.000 claims description 2
- 108010031133 Transferrin-Binding Protein A Proteins 0.000 claims description 2
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 claims description 2
- 229960003983 diphtheria toxoid Drugs 0.000 claims description 2
- 101150002054 galE gene Proteins 0.000 claims description 2
- 229930182830 galactose Natural products 0.000 claims description 2
- GZQKNULLWNGMCW-PWQABINMSA-N lipid A (E. coli) Chemical group O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O1 GZQKNULLWNGMCW-PWQABINMSA-N 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 229960000814 tetanus toxoid Drugs 0.000 claims description 2
- STCOOQWBFONSKY-UHFFFAOYSA-N tributyl phosphate Chemical compound CCCCOP(=O)(OCCCC)OCCCC STCOOQWBFONSKY-UHFFFAOYSA-N 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 description 7
- 229920001184 polypeptide Polymers 0.000 description 6
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16299609P | 2009-03-24 | 2009-03-24 | |
| US61/162,996 | 2009-03-24 | ||
| PCT/IB2010/000735 WO2010109325A2 (en) | 2009-03-24 | 2010-03-24 | Combinations including pneumococcal serotype 14 saccharide |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015121897A Division JP2015163651A (ja) | 2009-03-24 | 2015-06-17 | 肺炎球菌血清型14の糖を含む組み合わせ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012521404A JP2012521404A (ja) | 2012-09-13 |
| JP2012521404A5 true JP2012521404A5 (enExample) | 2013-05-09 |
| JP5806204B2 JP5806204B2 (ja) | 2015-11-10 |
Family
ID=42352288
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012501410A Expired - Fee Related JP5806204B2 (ja) | 2009-03-24 | 2010-03-24 | 肺炎球菌血清型14の糖を含む組み合わせ |
| JP2015121897A Ceased JP2015163651A (ja) | 2009-03-24 | 2015-06-17 | 肺炎球菌血清型14の糖を含む組み合わせ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015121897A Ceased JP2015163651A (ja) | 2009-03-24 | 2015-06-17 | 肺炎球菌血清型14の糖を含む組み合わせ |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20120064104A1 (enExample) |
| EP (1) | EP2411044A2 (enExample) |
| JP (2) | JP5806204B2 (enExample) |
| CN (1) | CN102421449A (enExample) |
| AU (1) | AU2010227221B2 (enExample) |
| CA (1) | CA2756398A1 (enExample) |
| NZ (1) | NZ595223A (enExample) |
| RU (2) | RU2549438C2 (enExample) |
| WO (1) | WO2010109325A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2258851A1 (en) | 1999-05-19 | 2010-12-08 | Novartis Vaccines and Diagnostics S.r.l. | Combination neisserial compositions |
| GB0316560D0 (en) | 2003-07-15 | 2003-08-20 | Chiron Srl | Vesicle filtration |
| AR086405A1 (es) | 2011-05-17 | 2013-12-11 | Glaxosmithkline Biolog Sa | Vacuna de streptococcus pneumoniae |
| US9427476B2 (en) | 2012-05-24 | 2016-08-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Multivalent meningococcal conjugates and methods for preparing conjugates |
| NZ630133A (en) * | 2012-06-14 | 2016-10-28 | Novartis Ag | Vaccines for serogroup x meningococcus |
| CA2875391A1 (en) | 2012-07-27 | 2014-01-30 | Institut National De La Sante Et De La Recherche Medicale | Cd147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia |
| CA2937186C (en) * | 2014-01-21 | 2022-11-01 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
| WO2015183676A1 (en) * | 2014-05-29 | 2015-12-03 | Kapre Subhash V | Synthetic peptides as carriers for conjugation with polysaccharides |
| US9107906B1 (en) | 2014-10-28 | 2015-08-18 | Adma Biologics, Inc. | Compositions and methods for the treatment of immunodeficiency |
| US10738338B2 (en) | 2016-10-18 | 2020-08-11 | The Research Foundation for the State University | Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate |
| US10259865B2 (en) | 2017-03-15 | 2019-04-16 | Adma Biologics, Inc. | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection |
| WO2023132795A2 (en) * | 2022-01-05 | 2023-07-13 | National University Of Singapore | Modified bacterial glycans and conjugates thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ587398A (en) * | 2002-08-02 | 2012-03-30 | Glaxosmithkline Biolog Sa | Neisserial bleb preparations and vaccines comprising them |
| HUE032903T2 (hu) * | 2005-12-22 | 2017-11-28 | Glaxosmithkline Biologicals Sa | Streptococcus pneumoniae kapszulárispoliszacharid-konjugátumok |
-
2010
- 2010-03-24 EP EP10714681A patent/EP2411044A2/en not_active Withdrawn
- 2010-03-24 RU RU2011142747/15A patent/RU2549438C2/ru not_active IP Right Cessation
- 2010-03-24 AU AU2010227221A patent/AU2010227221B2/en not_active Ceased
- 2010-03-24 JP JP2012501410A patent/JP5806204B2/ja not_active Expired - Fee Related
- 2010-03-24 WO PCT/IB2010/000735 patent/WO2010109325A2/en not_active Ceased
- 2010-03-24 NZ NZ595223A patent/NZ595223A/en not_active IP Right Cessation
- 2010-03-24 CN CN2010800212325A patent/CN102421449A/zh active Pending
- 2010-03-24 CA CA2756398A patent/CA2756398A1/en not_active Abandoned
- 2010-03-24 US US13/260,550 patent/US20120064104A1/en not_active Abandoned
-
2014
- 2014-05-30 RU RU2014122163/15A patent/RU2014122163A/ru not_active Application Discontinuation
-
2015
- 2015-06-17 JP JP2015121897A patent/JP2015163651A/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012521404A5 (enExample) | ||
| Barel et al. | Classical and novel strategies to develop a Shigella glycoconjugate vaccine: from concept to efficacy in human | |
| Costantino et al. | The design of semi-synthetic and synthetic glycoconjugate vaccines | |
| JP2023036953A (ja) | 肺炎連鎖球菌多糖-タンパク質コンジュゲートの免疫原性の増強 | |
| RU2014122163A (ru) | Комбинации, включающие сахарид пневмококка серотипа 14 | |
| RU2011142774A (ru) | Комбинации менингококкового фактор н-связывающего белка и пневмококковых сахаридных конъюгатов | |
| JP2007507487A5 (enExample) | ||
| JP2020533442A (ja) | 肺炎球菌多糖体および免疫原性多糖体−キャリアタンパク質コンジュゲートでのその使用 | |
| JP2020533439A (ja) | 肺炎球菌多糖体および免疫原性多糖体−キャリアタンパク質コンジュゲートでのその使用 | |
| RU2012149618A (ru) | Менингококковые полипептиды fhbp | |
| JP2011042693A5 (enExample) | ||
| TR201811681T4 (tr) | İmmünojenik bileşimler. | |
| US6132723A (en) | Immunogenic oligosaccharide compositions | |
| RU2005119640A (ru) | Множественные варианты менингококкового белка nmbi1870 | |
| JP2014503172A5 (enExample) | ||
| BR112014018815B1 (pt) | Composição imunogênica compreendendo conjugado proteína-polissacarídeo x de n. meningitidis | |
| BE1024465A1 (fr) | Vaccin | |
| Sanders et al. | Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines | |
| US5695768A (en) | Immunostimulating activity of Streptococcus pneumoniae serotype 8 oligosaccharides | |
| US20020119162A1 (en) | Synthetic vaccine agents | |
| JP2015532276A (ja) | 非直鎖状糖コンジュゲート | |
| EP3544637B1 (en) | Native omv-antigen conjugates and use thereof | |
| JP2006528936A5 (enExample) | ||
| JP2012524099A5 (enExample) | ||
| US20040191264A1 (en) | Synthetic vaccine agents |